EMVision Medical Devices (ASX:EMV) said it has started the process of activating the Liverpool Hospital in Sydney for the trial of its emu bedside brain scanner this week, with Mount Sinai Hospital in New York set to follow later this month, according to a Tuesday filing with the Australian bourse.
The two new sites bring the total number of activated trial locations to five, with a sixth site expected to join shortly, the filing said.